A multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of estradiol [Evamist] metered-dose transdermal spray (MDTS) in the treatment of vasomotor symptoms in postmenopausal women

Trial Profile

A multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of estradiol [Evamist] metered-dose transdermal spray (MDTS) in the treatment of vasomotor symptoms in postmenopausal women

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2014

At a glance

  • Drugs Estradiol (Primary)
  • Indications Hot flashes; Menopausal syndrome; Menopause; Vasomotor symptoms
  • Focus Registrational; Therapeutic Use
  • Sponsors Lumara Health
  • Most Recent Events

    • 06 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 06 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 01 Jun 2008 Results have been published in Obstetrics and Gynecology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top